Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response
采用DNA启动-MVA加强免疫方案的治疗性乙型肝炎疫苗需要额外使用重组HBsAg进行启动免疫,以诱导足够的抗体反应。
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1771887
Kerth, Hélène A; Kächele, Martin; Müller, Nikolas; Singh, Swati; Tulessin, Margaret; Sacherl, Julia; Ates Öz, Edanur; Su, Jinpeng; Bester, Romina; Miko, Susanne; Steiger, Katja; Mogler, Carolin; Busch, Dirk H; Wettengel, Jochen M; Protzer, Ulrike; Kosinska, Anna D